Defects of neutrophil mobility are being recognised in an increasing number of patients with recurrent pyogenic infections.' In many patients it is difficult to determine whether the neutrophil defect is primary or secondary. As with other types of immunodeficiency, family studies, in which inheritance can be established, afford a good opportunity to define the disorder.2 We describe a family with both a dominantly-inherited defect of neutrophil mobility and Waardenberg's syndrome (lateral displacement of the epicanthic folds, deafness, and pigmentary defects of hair and iris). Investigations Cases 4 and 6 were investigated because of splenomegaly and frequent infections; their brother (Case 5) was investigated too although he was symptomless. Their blood counts and urine samples were normal, and lymph node biopsies and marrow films showed only reactive hyperplasia and no evidence of storage disease. Blood count, and levels of sweat sodium, and a-l-antitrypsin were normal in Cases 8, 9, and 10, although blood neutrophil counts did not rise above 5*4 x 109/l even during severe infections. Tests of specific immunity (Table 1) and complement  (Table 2) on Cases 6, 7, 8, 9 , and 10 were normal apart from high serum IgM levels and defective neutrophil mobility in Cases 6, 8, 9, and 10, all of whom had had splenomegaly and frequent infections. The serum IgM of the patients with raised levels was heterogeneous in immunoelectrophoresis and included both kappa and lambda light chains.
The neutrophil mobility of Cases 6, 8, 9, and 10 was repeatedly lower that that of the controls and was lower than the mean mobility of 110±15 ,um for healthy donors' neutrophils previously established in our laboratory (Table 3) . Increased mobility of the neutrophils of Cases 8, 9, and 10 was seen in the presence of 10-3 mol/l levamisole and 5-10 mmol/l ascorbic acid. The patients' blood neutrophil count was normal, although leucocytosis during infections was slight. Bacterial killing by neutrophils was normal and the only defect was that of mobility. We have, in accordance with current recommendations, avoided the term 'chemotaxis defect' since the commonly used leading front method for measuring neutrophil mobility5 does not always distinguish chemokinesis from chemotaxis.6 In vitro, the mobility ofneutrophils from Cases 8, 9, and 10 was improved in the presence of ascorbic acid and that of Case 8 was also improved by levamisole. Studies in other patients with neutrophil mobility defects7-9 suggest that ascorbic acid and levamisole act by way of an alteration of the ratios of cyclic-AMP to cyclic-GMP which in turn influence microtubule assembly.'0 The drug effect therefore is consistent with a possible underlying biochemical abnormality but it gives little indication of its nature. Neither levamisole nor ascorbic acid treatment was of therapeutic benefit in Case 8, although the lack of response may have been due to pre-existing lung damage. Both the clinical features and laboratory results in Cases 6, 8, 9, and 10 are consistent with a primary defect of neutrophil mobility. The similar symptoms in Cases 3 and 4 suggest that they had the same disease. The case for dominant inheritance in this family is strong and we are not aware of previous reports of dominantlyinherited defects of neutrophil mobility.
Waardenberg's syndrome has a dominant inheritance11 though the penetrance is variable. Phenotypic features found in this family include white forelocks, premature greying, perceptive deafness and, in Case 10, ptosis and eye abnormalities. The occurrence of a neutrophil mobility defect in our family with Waardenberg's syndrome may result from a single metabolic defect or it may be a coincidence. The case for a common mechanism could derive support from the neutrophil mobility and bacterial killing defects which occur in another disorder of pigmentation: Chediak Higashi syndrome.7 8 Not enough patients with Waardenberg's syndrome have been studied to exclude this hypothesis, but Waardenberg's syndrome is not rare and we know of only one other patient in whom infections were a problem.12 That patient had a ventriculo-septal defect and died with pneumonia. In other reviews and case reports of Waardenberg's syndrome excess infections are not reported, and there was no clear evidence for excess infections in Case 1 in our family, so the possibility that this finding was coincidental remains.
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